Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mastocytosis × Cromolyn Sodium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 2 Mastocytosis 1

Interventions

masitinib 2 midostaurin 1 fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Stem Cell Transplantation 1 Radiotherapy 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Imatinib Mesylate 1 Dasatinib 1 Cyclophosphamide 1 Cromolyn Sodium 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01701843 2025-02-24

Cromoglicate in Mastocytosis

LEO Pharma

Phase 2 Terminated

Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡